Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT04619004 |
| Consolidated Lead Sponsor | Daiichi Sankyo |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 277 participants (ACTUAL) |
| Registered Start Date | 2021-02-02 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert, AZ | Open Hospital Dossier -> |
| City of Hope National Medical Center | Duarte, CA | Open Hospital Dossier -> |
| UC San Diego Health and Moores Cancer Center | San Diego, CA | Open Hospital Dossier -> |
| USC Norris Comprehensive Cancer Center and Keck Medicine | Los Angeles, CA | Open Hospital Dossier -> |
Related Filings Across Meru Platforms
Verified cross-ledger federal filings for Daiichi Sankyo across sibling Meru public-data platforms.
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.